Germany
Japan
United Kingdom
China
Research Areas
View as table Download
Mouse Monoclonal CD8 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal TNFRSF8 (CD30) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal CD79a Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal CD1a Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal CD2 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal CD23 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal PECAM1 (CD31) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal PTPRC (CD45) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal NCAM1 (CD56) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal CD68 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD34 (Clone My10)
| Applications | FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-18 (Clone 125-2H)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-HLA class II (Clone F3.3)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
5 Weeks
Recombinant Anti-IL-2R (Clone Daclizumab)
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD19 (Clone HD37)
| Applications | FC, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone MT310)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone 4G7)
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-2 (Clone LNKB-2)
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone 13B8.2)
| Applications | EIA, ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-18 (Clone SAIC-24B-4)
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD11c (Clone N418)
| Applications | ELISA |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD30 (Clone Ki-4)
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | ELISA, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
| Applications | Bl, FC, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD64 (Clone H22)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-IL2R (Clone AHT107)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL2R (Clone AHT54)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-10 (Clone 9D7)
| Applications | ELISA, IF, IHC, IP, Neutralize |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone DB81)
| Applications | ELISA, FC, Neutralize |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD56 (Clone NCAM12.19)
| Applications | ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD20 (Clone CAT-13.6E12)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone CAT-13.1E10)
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD31 (Clone BAG-85D10)
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone BAG 75E5)
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD10 (Clone FR4D11)
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD1a (Clone CBT6)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Isotypes
- IgG1, kappa
Filter by
Category
Target Symbol
- IL2RA (6)
- CD4 (4)
- CD19 (3)
- TNF (3)
- CD1A (2)
- CD74 (2)
- CD8A (2)
- IL18 (2)
- ITGA2B (2)
- MS4A1 (2)
- NCAM1 (2)
- PECAM1 (2)
- TNFRSF8 (2)
- CASP1 (1)
- CD2 (1)
- CD22 (1)
- CD274 (1)
- CD33 (1)
- CD34 (1)
- CD3E (1)
- CD68 (1)
- CD79A (1)
- FCER2 (1)
- FCGR1A (1)
- HLA CLASS II (1)
- IL10 (1)
- IL2 (1)
- IL6R (1)
- ITGAX (1)
- MME (1)
- PTPRC (1)
- TLR3 (1)
- TLR9 (1)
Reactivities
Applications
Antibody Hosts
Clonalities
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
Assay Types
Families
Pathways
- Cell adhesion molecules (CAMs) (5)
- Hematopoietic cell lineage (4)
- Primary immunodeficiency (3)
- T cell receptor signaling pathway (2)
- Toll-like receptor signaling pathway (2)
- Amyotrophic lateral sclerosis (ALS) (1)
- Antigen processing and presentation (1)
- B cell receptor signaling pathway (1)
- Cytokine-cytokine receptor interaction (1)
- Cytosolic DNA-sensing pathway (1)
- Fc gamma R-mediated phagocytosis (1)
- Leukocyte transendothelial migration (1)
- Lysosome (1)
- NOD-like receptor signaling pathway (1)
- Prion diseases (1)